Board of Directors
Non-Executive Chair:
James A. Bianco, M.D.
Principal Founder, CEO, Cell Therapeutics, Inc.
Other Directors:
Jack W. Singer, M.D.
Founder, Director, and Chief Medical Officer, Cell Therapeutics, Inc.
Co-inventor of the Genetic Polymer™ technology
Fred W. Telling, Ph.D.
CTI Board Member and former Vice President of Corporate Policy and Strategic Management for Pfizer, Inc.
David Cosman, Ph.D.
Former Distinguished Fellow and Research Director for Amgen and
Vice President, Molecular Biology for Immunex Corporation
Carl J. March, Ph.D., MBA
Former Senior Vice President of Information Technology and Biochemical Sciences for Immunex Corporation.
Stewart D. Chipman, Ph.D.
Chief Scientific Officer, President and Interim CEO, Aequus
Executive Management
Stewart D. Chipman, Ph.D., Chief Scientific Officer, President and Interim CEO
Dr. Chipman, co-inventor of the Genetic Polymer™ technology and Vice President of Research at CTI, is a biotech executive with over 15 years of experience in building and leading scientific teams focused on the discovery and development of novel human therapeutics in the fields of inflammation, metabolic bone diseases, and cancer biology. As Director of Biomolecular Screening at Immunex and Associate Director, Research at Amgen, Dr. Chipman provided expertise in high-throughput screening robotics and synthetic chemistry for small molecule lead discovery. Prior to joining Immunex, he was Director of Biology at ArQule in Boston. Dr. Chipman received his B.S. in Biology at Boston University and Ph.D. in Biochemistry from the Boston University School of Medicine. Prior to pursuing his career in biotech, Dr. Chipman was an Associate Professor of Medicine at The Johns Hopkins University Medical School. He has co-authored more than 40 peer-reviewed scientific papers and is a co-inventor on seven U.S. and foreign patents.
